157 related articles for article (PubMed ID: 7488187)
21. Determination of chloral hydrate and its metabolites (trichloroethanol and trichloracetic acid) in human plasma and urine using electron capture gas chromatography.
Humbert L; Jacquemont MC; Leroy E; Leclerc F; Houdret N; Lhermitte M
Biomed Chromatogr; 1994; 8(6):273-7. PubMed ID: 7888728
[TBL] [Abstract][Full Text] [Related]
22. The metabolism of trichloroethylene and its metabolites in the perfused liver.
Kawamoto T; Hobara T; Kobayashi H; Iwamoto S; Sakai T; Imamura A; Koshiro A
J Toxicol Sci; 1987 May; 12(2):87-96. PubMed ID: 3625828
[TBL] [Abstract][Full Text] [Related]
23. Biliary excretion of trichloroethylene and its metabolites in dogs.
Hobara T; Kobayashi H; Kawamoto T; Sato T; Iwamoto S; Hirota S; Sakai T
Toxicol Lett; 1986; 32(1-2):119-22. PubMed ID: 3738923
[TBL] [Abstract][Full Text] [Related]
24. Aldehyde dismutation catalyzed by pulmonary carbonyl reductase: kinetic studies of chloral hydrate metabolism to trichloroacetic acid and trichloroethanol.
Hara A; Yamamoto H; Deyashiki Y; Nakayama T; Oritani H; Sawada H
Biochim Biophys Acta; 1991 Sep; 1075(1):61-7. PubMed ID: 1892867
[TBL] [Abstract][Full Text] [Related]
25. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol.
Bronley-DeLancey A; McMillan DC; McMillan JM; Jollow DJ; Mohr LC; Hoel DG
Environ Health Perspect; 2006 Aug; 114(8):1237-42. PubMed ID: 16882532
[TBL] [Abstract][Full Text] [Related]
26. Kinetics and metabolism of chloral hydrate in children: identification of dichloroacetate as a metabolite.
Henderson GN; Yan Z; James MO; Davydova N; Stacpoole PW
Biochem Biophys Res Commun; 1997 Jun; 235(3):695-8. PubMed ID: 9207222
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
28. The cholecystohepatic circulation of trichloroethylene and its metabolites in dogs.
Hobara T; Kobayashi H; Kawamoto T; Iwamoto S; Sakai T
Toxicology; 1987 Jun; 44(3):283-95. PubMed ID: 3576627
[TBL] [Abstract][Full Text] [Related]
29. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
Ross MK; Pegram RA
Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
[TBL] [Abstract][Full Text] [Related]
30. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
Stiborová M; Stiborová-Rupertová M; Borek-Dohalská L; Wiessler M; Frei E
Chem Res Toxicol; 2003 Jan; 16(1):38-47. PubMed ID: 12693029
[TBL] [Abstract][Full Text] [Related]
31. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine.
Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP
Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032
[TBL] [Abstract][Full Text] [Related]
32. A modified immuno-enriched 32P-postlabeling method for analyzing the malondialdehyde-deoxyguanosine adduct, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)- pyrimido[1,2-alpha]purin-10(3H)one in human tissue samples.
Sun X; Nair J; Bartsch H
Chem Res Toxicol; 2004 Feb; 17(2):268-72. PubMed ID: 14967015
[TBL] [Abstract][Full Text] [Related]
33. Lack of formic acid production in rat hepatocytes and human renal proximal tubule cells exposed to chloral hydrate or trichloroacetic acid.
Lock EA; Reed CJ; McMillan JM; Oatis JE; Schnellmann RG
Toxicology; 2007 Feb; 230(2-3):234-43. PubMed ID: 17161896
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
35. Development of monoclonal antibodies to the malondialdehyde-deoxyguanosine adduct, pyrimidopurinone.
Sevilla CL; Mahle NH; Eliezer N; Uzieblo A; O'Hara SM; Nokubo M; Miller R; Rouzer CA; Marnett LJ
Chem Res Toxicol; 1997 Feb; 10(2):172-80. PubMed ID: 9049428
[TBL] [Abstract][Full Text] [Related]
36. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo.
Schuler D; Budiawan B; Eder E
Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122
[TBL] [Abstract][Full Text] [Related]
37. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
38. Absence of DNA adduct formation by phenobarbital, polychlorinated biphenyls, and chlordane in mouse liver using the 32P-postlabeling assay.
Whysner J; Montandon F; McClain RM; Downing J; Verna LK; Steward RE; Williams GM
Toxicol Appl Pharmacol; 1998 Jan; 148(1):14-23. PubMed ID: 9465259
[TBL] [Abstract][Full Text] [Related]
39. Sedative/hypnotic effects of chloral hydrate in the neonate: trichloroethanol or parent drug?
Mayers DJ; Hindmarsh KW; Gorecki DK; Sankaran K
Dev Pharmacol Ther; 1992; 19(2-3):141-6. PubMed ID: 1340434
[TBL] [Abstract][Full Text] [Related]
40. Structure, tumorigenicity, microsomal metabolism, and DNA binding of 7-Nitrodibenz[a,h]anthracene.
Fu PP; Von Tungeln LS; Chiu LH; Zhan DJ; Deck J; Bucci T; Wang JC
Chem Res Toxicol; 1998 Aug; 11(8):937-45. PubMed ID: 9705756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
